American Regent, Inc.: Drug Recall

Recall #D-0503-2024 · 05/14/2024

Class II: Risk

Recall Details

Recall Number: D-0503-2024
Classification: Class II
Product Type: Drug
Recalling Firm: American Regent, Inc.
Status: Terminated
Date Initiated: 05/14/2024
Location: New Albany, OH, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 4,136 cartons (10 vials in each carton)

Reason for Recall

Lack of Assurance of Sterility.

Product Description

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, For Intravenous Use Only, Mfd for: Civica, Inc., Lehi, UT 84043; Mfd by: American Regent, Inc., New Albany, OH 43054. NDC 72572-470-10

Distribution Pattern

UT only

Other Recalls by American Regent, Inc.

Class II: Risk 04/18/2025

Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Class II: Risk 04/18/2025

Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Class II: Risk 11/11/2024

Presence of Particulate Matter: Potential for glass delamination from the vials.
Class II: Risk 11/11/2024

Presence of Particulate Matter: Potential for glass delamination from the vials.
Class II: Risk 11/11/2024

Presence of Particulate Matter: Potential for glass delamination from the vials.

View all recalls by American Regent, Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.